The effect of AG1478 combined with Ciaplatin on tumor growth for orthotopic xenografts of human glioblastoma in nude mice

HUANG Yan-lin,LAN Qing,DIAO Yi

2010-01-01

Abstract:Objective To evaluate the anti-tumor activity of an aqueous form of AG1478,and analyze the antitumor efficacy of combination of AG1478 with Cisplatin in the treatment for orthotopic xenografts from human gliobastoma multiforme tissues.Methods Orthotopic xenograft model of human gliobastoma multiforme with stable EGFRⅧ expression was established as described previously.On day 3 postinnoculation,40 mice were divided into 4 groups randomly with 10 in each group,then 4 groups of mice received i.p.injections of AG1478(25mg/kg),Cisplatin(3mg/kg),AG1478+ Cisplatin(25mg/kg every time +3mg/kg)and PBS(0.1ml/20g)respectively every 2 days for 4 times,then their survival time was observed until the mice bearing xenografts died naturally.The experiment was repeated,in another 40 mice the same types of treatment were initiated on day 3.On day 14 after innnoculation,every group of mice were sacrified.Mice brains were removed from the cranial cavity,fixed with formalin,bisected coronally,and embedded in paraffin.Serial sections were stained with H&E to observe tumor appearance and to measure the maximum or minimun diameter under light microscope to estimate tumor volume.The expression of EGFR,phosphorylated EGFR or Ki-67 in the xenografts were detected by immunochemical methods,and apoptosis were detected by TUNEL method.Results Compared with PBS group,the suvival were strikingly prolonged,and volume of xenografts were reduced by the combination of Cisplatin with AG1478.Meanwhile,the combined application could significantly decrease proliferative activity and increase apoptotic rate,but no effect could be seen for single drug.Conclusions The combination of AG1478 with Cisplatin can significantly increase the activities against tumor growth.This provides the rationale for its combination with both chemotherapy and other EGFR therapeutics.